Amphastar P
Price & Volume
Stats
See more52W Range | $17.03-$31.26 |
Market Cap | $936M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $719.8M |
Revenue Growth (YoY) | -1.8% |
Gross Profit (12 Mos) | $356M |
Diluted EPS | $2.03 |
News
See moreYahoo Finance • 27 days ago
NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know
Yahoo Finance • last month
Wells Fargo Sees Amphastar Pharmaceuticals, Inc.’s (AMPH) AMP-007 as Key to Mid- to High-Single-Digit Growth
Yahoo Finance • 4 months ago
Amphastar Director Sells 16,679 Shares for $441,800
Yahoo Finance • 4 months ago
Weekly Buzz: CYTK Scores First FDA Approval, INSM Ends Rhinosinusitis Study, XOMA Acquires GBIO
About
CEO | Dr. Yongfeng Zhang Ph.D. |
CFO | Mr. William J. Peters M.B.A. |
Address | 11570 6th Street, Rancho Cucamonga, CA, United States, 91730 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 1,976 |
